Global Security · Public broadcaster · Archived
U.S. missile stockpiles dwindle. And, FDA weighs approval of flu shots with mRNA tech
The U.S. Army's missile stockpile is dwindling and could take years to replenish. And, the Food and Drug Administration is deciding whether to approve a flu vaccine with mRNA technology.
- Source published
- 5 Aug 2026, 13:54 CEST
Publication time from the source RSS/feed - Captured by GC
- 6 Aug 2026, 23:01 CEST
When GlobalsConflicts first captured this item. - Source
- NPR - World
- Trust
- medium · one source, verify further
- Source quality
- good
public broadcaster or established media source from a direct trail - Actors
- open
Brief
The U.S. Army's missile stockpile is dwindling and could take years to replenish. And, the Food and Drug Administration is deciding whether to approve a flu vaccine with mRNA technology.
StatusArchivedThis page was frozen once the report rolled out of the current window. Content is no longer updated or cross-checked against new sources.
What was reported
The U.S. Army's missile stockpile is dwindling and could take years to replenish. And, the Food and Drug Administration is deciding whether to approve a flu vaccine with mRNA technology.